|Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market|
Home / News
In IH, Veropharm's net income under IFRS grew by 28.2% to $7.5 mln.
In the I half of 2006, Veropharm OJSC net income under IFRS grew by 28.2% to $7.5 mln from $5.8 mln for the same period of last year, the Company says.
Veropharm's sales rose by 34.3% and totaled $45.2 mln. The Company's gross profit grew by 37.1% to $27.8 mln from $20.3 mln. Margin of gross profit increased from 60.1% to 61.4%.
EBITDA rose by 27.2% to $12.1 mln from $9.5 mln. EBITDA margin totaled 16.5% in the IH.
Veropharm is one of Russian leading pharmaceutical manufactures. It produces above 180 pharmaceuticals, as well as medical plasters of more than 100 kinds. The Company's production facilities are situated in Belgorod, Voronezh and Pokrov (Vladimir Region).
51% of Veropharm shares are held by Pharmacy Chain 36.6 ; 49% are floating securities. In April 2006, Pharmacy Chain 36.6 and Troika Dialog floated 49% of Veropharm shares worth $139.7 million.